Open AccessUse of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Verdict 2
Author(s) -
Charles A. Herzog
Publication year - 2016
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.09470916
Subject(s) - medicine , atrial fibrillation , intensive care medicine , warfarin , antithrombotic , guideline , hemodialysis , aspirin , kidney disease , dialysis , cardiology , pathology
Philosophically, the concept of peer review of a debate on the merits of oral anticoagulation [specific agent unspecified] for end-stage renal disease patients with atrial fibrillation on hemodialysis ([1][1],[2][2]) is a bit nebulous, because the outcome of debates depends on more than enumerating
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom